InsiderClue
Insiders · Profile

SCHELLER RICHARD H

Director at Maze Therapeutics · Director at Alector · See Remarks at BridgeBio Pharma · and 2 more. Filing since 10 Aug 2017. CIK 0001214133

MAZE Maze Therapeutics, Inc. Director · 1 trade ALEC Alector, Inc. Director · 4 trades BBIO BridgeBio Pharma, Inc. See Remarks · 5 trades ORIC Oric Pharmaceuticals, Inc. Director · 12 trades XENE Xenon Pharmaceuticals Inc. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
MAZE Maze Therapeutics, Inc.
15 Sep 2025
Director
Sold at will
20,744
$464.03K
100%
ALEC Alector, Inc.
22 Aug 2024
Director
Sold at will
44,250
$228.39K
55.8%
ALEC Alector, Inc.
5 Aug 2021
Director
Sold, plan not stated
56,260
$1.56M
100%
BBIO BridgeBio Pharma, Inc.
4 Aug 2021
See Remarks
Sold, plan not stated
13,777
$733.32K
23.1%
ALEC Alector, Inc.
2 Jul 2021
Director
Sold, plan not stated
9,981
$310.81K
100%
ORIC Oric Pharmaceuticals, Inc.
24 May 2021
Director
Sold, plan not stated
100
$2.50K
0.3%
ORIC Oric Pharmaceuticals, Inc.
21 May 2021
Director
Sold, plan not stated
1,231
$31.01K
3.0%
ORIC Oric Pharmaceuticals, Inc.
20 May 2021
Director
Sold, plan not stated
659
$16.53K
1.6%
ORIC Oric Pharmaceuticals, Inc.
18 May 2021
Director
Sold, plan not stated
2,800
$70.96K
6.4%
ORIC Oric Pharmaceuticals, Inc.
17 May 2021
Director
Sold, plan not stated
500
$12.53K
1.1%
ORIC Oric Pharmaceuticals, Inc.
14 May 2021
Director
Sold, plan not stated
4,615
$117.12K
9.4%
ORIC Oric Pharmaceuticals, Inc.
13 May 2021
Director
Sold, plan not stated
100
$2.50K
0.2%
ORIC Oric Pharmaceuticals, Inc.
12 May 2021
Director
Sold, plan not stated
103
$2.58K
0.2%
ORIC Oric Pharmaceuticals, Inc.
11 May 2021
Director
Sold, plan not stated
300
$7.55K
0.6%
ORIC Oric Pharmaceuticals, Inc.
30 Apr 2021
Director
Sold, plan not stated
100
$2.52K
0.2%
ORIC Oric Pharmaceuticals, Inc.
28 Apr 2021
Director
Sold, plan not stated
200
$5.02K
0.4%
ORIC Oric Pharmaceuticals, Inc.
1 Apr 2021
Director
Sold, plan not stated
200
$5.00K
0.4%
BBIO BridgeBio Pharma, Inc.
21 Dec 2020
See Remarks
Sold, plan not stated
60,401
$3.95M
56.8%
BBIO BridgeBio Pharma, Inc.
18 Dec 2020
See Remarks
Sold, plan not stated
30,000
$1.95M
22.0%
BBIO BridgeBio Pharma, Inc.
15 Dec 2020
See Remarks
Sold, plan not stated
31,443
$1.90M
18.7%
BBIO BridgeBio Pharma, Inc.
16 Sep 2020
See Remarks
Sold, plan not stated
25,000
$937.50K
15.3%
ALEC Alector, Inc.
4 Feb 2020
Director
Sold, plan not stated
10,000
$296.70K
50.0%
XENE Xenon Pharmaceuticals Inc.
10 Aug 2017
Director
Bought
7,000
$19.95K
opened
23 decisions on file.